Literature DB >> 18494864

Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects.

Beom-Jun Kim1, Tae Yong Kim, Jung-Min Koh, Hong-Kyu Kim, Joong-Yeol Park, Ki-Up Lee, Young Kee Shong, Won Bae Kim.   

Abstract

BACKGROUND: The metabolic syndrome (MS) is associated with increased life-time risk for atherosclerotic cardiovascular disease. While some reports suggest that MS and/or insulin resistance is associated with low serum free T4 (FT4) level in euthyroid subjects, this remains a controversial issue.
OBJECTIVE: To clarify the association of serum FT4 level with presence of MS and its components in healthy euthyroid subjects. SUBJECTS AND MEASUREMENTS: For 44,196 euthyroid subjects (including 25,147 males) not taking thyroid hormone or antithyroid-drug and without liver or renal disease who participated in a routine health screening examination, we measured serum FT4, high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), fasting glucose, blood pressure (BP), height, weight, and waist circumference. Subjects were categorized into five groups according to their serum FT4 concentration. The association of FT4 quintiles with clinical and metabolic parameters of MS was analysed by significance test for linearity, and logistic regression analysis was used to calculate odds ratios (ORs) for risk of MS and each of its components, before and after adjustment for age.
RESULTS: In males, serum FT4 concentrations were positively associated with BP, fasting glucose, HDL-C, and TG levels, and negatively associated with waist circumference after adjustment for age (P for trend = 0.033 to < 0.001). Females also showed similar findings except that FT4 had no correlation with TG after adjustment for age (all P for trend < 0.001 except TG). The negative association between FT4 and waist circumference was not present in younger male subjects (< 50 years), and the positive association between FT4 and BP was more prominent in younger female subjects (< 50 years) than in older females (P < 0.05). In both sexes, the ORs for elevated BP and elevated fasting glucose were significantly higher in subjects in the highest FT4 quintile than those in the lowest FT4 quintile, while the ORs for abdominal obesity and low HDL-C were significantly lower. Subjects in the higher FT4 quintiles had a significantly lower prevalence of MS than those in the lowest FT4 quintile, but such differences disappeared after adjustment for age in both males and in females.
CONCLUSION: These results suggest that the interaction between serum FT4 and MS components could be different according to age as well as gender in euthyroid subjects. Although thyroid hormone significantly affected each component of MS, there was no association between serum FT4 level and presence of MS after adjustment for age in healthy euthyroid subjects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18494864     DOI: 10.1111/j.1365-2265.2008.03304.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  32 in total

1.  Is thyroid-stimulating hormone within the normal reference range a risk factor for atherosclerosis in women?

Authors:  Anna Boggio; Fulvio Muzio; Michela Fiscella; Domenico Sommariva; Adriana Branchi
Journal:  Intern Emerg Med       Date:  2011-12-28       Impact factor: 3.397

2.  Thyroid function and prevalent and incident metabolic syndrome in older adults: the Health, Ageing and Body Composition Study.

Authors:  Avantika C Waring; Nicolas Rodondi; Stephanie Harrison; Alka M Kanaya; Eleanor M Simonsick; Iva Miljkovic; Suzanne Satterfield; Anne B Newman; Douglas C Bauer
Journal:  Clin Endocrinol (Oxf)       Date:  2012-06       Impact factor: 3.478

3.  Isolated hyperthyrotropinemia in childhood obesity and its relation with metabolic parameters.

Authors:  Tolga Unüvar; Ahmet Anık; Gönül Catlı; Ihsan Esen; Ayhan Abacı; Atilla Büyükgebiz; Ece Böber
Journal:  J Endocrinol Invest       Date:  2014-06-12       Impact factor: 4.256

4.  Low serum free thyroxine concentrations associate with increased arterial stiffness in euthyroid subjects: a population-based cross-sectional study.

Authors:  Jian Wang; Xuqin Zheng; Min Sun; Zhixiao Wang; Qi Fu; Yun Shi; Mengdie Cao; Zhenxin Zhu; Chuchen Meng; Jia Mao; Fan Yang; Xiaoping Huang; Jingjing Xu; Hongwen Zhou; Yu Duan; Wei He; Mei Zhang; Tao Yang
Journal:  Endocrine       Date:  2015-05-19       Impact factor: 3.633

5.  Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study.

Authors:  Bregje van Zaane; Alessandro Squizzato; Roeland Huijgen; Anton P van Zanten; Eric Fliers; Suzanne C Cannegieter; Harry R Büller; Victor E A Gerdes; Dees P M Brandjes
Journal:  Blood       Date:  2010-03-22       Impact factor: 22.113

6.  Incidence of Thyroid Dysfunction Facing Metabolic Syndrome: A Prospective Comparative Study with 9 Years of Follow-Up.

Authors:  Ladan Mehran; Atieh Amouzegar; Hengameh Abdi; Negar Delbari; Elham Madreseh; Maryam Tohidi; Mohammad Ali Mansournia; Fereidoun Azizi
Journal:  Eur Thyroid J       Date:  2021-01-27

Review 7.  Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Authors:  Bernadette Biondi; George J Kahaly; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

8.  Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects.

Authors:  Greet L Roef; Ernst R Rietzschel; Caroline M Van Daele; Youri E Taes; Marc L De Buyzere; Thierry C Gillebert; Jean-Marc Kaufman
Journal:  Thyroid       Date:  2013-11-14       Impact factor: 6.568

9.  FAT DISTRIBUTION AND METABOLIC PROFILE IN SUBJECTS WITH HASHIMOTO'S THYROIDITIS.

Authors:  U Mousa; Y Bozkuş; A Kut; C C Demir; N B Tutuncu
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jan-Mar       Impact factor: 0.877

10.  The metabolic syndrome in thyroid disease: A report from Nigeria.

Authors:  Anthonia O Ogbera; Sonny Kuku; Olusola Dada
Journal:  Indian J Endocrinol Metab       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.